The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy.
about
Influence of Arsenic on Global Levels of Histone Posttranslational Modifications: a Review of the Literature and Challenges in the FieldChemosensitivity enhancement toward arsenic trioxide by inhibition of histone deacetylase in NB4 cell line.Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.Heavy metal and junk DNA.Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo.Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.
P2860
The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The evolution of arsenic in th ...... tive oral, outpatient therapy.
@en
The evolution of arsenic in th ...... tive oral, outpatient therapy.
@nl
type
label
The evolution of arsenic in th ...... tive oral, outpatient therapy.
@en
The evolution of arsenic in th ...... tive oral, outpatient therapy.
@nl
prefLabel
The evolution of arsenic in th ...... tive oral, outpatient therapy.
@en
The evolution of arsenic in th ...... tive oral, outpatient therapy.
@nl
P2860
P356
P1433
P1476
The evolution of arsenic in th ...... tive oral, outpatient therapy.
@en
P2093
Farhad Ravandi-Kashani
Lorenzo Falchi
P2860
P304
P356
10.1002/CNCR.29852
P407
P577
2015-12-30T00:00:00Z